Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The John Paul II Medical Research Institute (JP2MRI) is a non-profit organization dedicated to advancing medical research through the use of ethically derived stem cells. The institute focuses on utilizing adult stem cells and induced pluripotent stem cells (iPSCs) to create disease models for drug discovery and therapeutic development. Their primary research areas include neurodegenerative diseases like ALS and Alzheimer's, as well as various forms of cancer and rare genetic disorders. By providing an ethical alternative to embryonic stem cell research, JP2MRI seeks to accelerate the delivery of regenerative medicine to patients. The organization also offers biobanking services and collaborates with other researchers to provide human-derived cell lines for ethical research. Their work bridges the gap between basic science and clinical application by focusing on personalized medicine and drug screening platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on John Paul II Medical Research Institute.